CIR’s 2019 Priorities A Botanical Garden; AHPA To Stay Tuned In
This article was originally published in The Rose Sheet
Executive Summary
The American Herbal Products Association vows to stay abreast of Cosmetic Ingredient Review activities, with ingredients of importance to its members sprinkled throughout the group’s 2019 priority list.
You may also be interested in...
CIR Expert Panel Wraps Five Ingredient Safety Assessments, Finalizes 2022 Priorities
Meeting virtually on 13-14 September, Cosmetic Ingredient Review's independent expert panel issued final safety assessments for red algae, tea tree and three other ingredients/groups, as well as eight tentative reports and five insufficient data announcements. The group also finalized its review priorities for 2022.
CIR Tackles Growing Natural Workload Against Backdrop Of Widely Held Safety Assumptions
CIR’s Expert Panel reached tentative safe conclusions for a number of naturally derived ingredients at its December meeting, while identifying data deficiencies for others. In his post-meeting report, Executive Director Bart Heldreth highlights recent commentaries in scientific journals defying the notion that natural is necessarily safe and lauding CIR as the preeminent ingredient safety authority.
FDA Proposes Priorities For Cosmetic Ingredient Review: Mica, Probiotics, CBD
Nakissa Sadrieh, director of cosmetics at FDA and the agency’s CIR liaison, floated the three potential review priorities at the CIR Expert Panel’s April 8-9 meeting in Washington. It’s the most for-cause targets proposed by the agency in recent memory, and CIR leadership noted that they pose considerable challenges.